CL vs EMR
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 02, 2026
CL
63.3
AI Score
VS
CL Wins
EMR
51.0
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | CL | EMR | Winner |
|---|---|---|---|
| Revenue | 8.91B | 5.32B | EMR |
| Net Income | 1.22B | 646.00M | EMR |
| Net Margin | 13.7% | 12.1% | EMR |
| ROE | 6.0% | 445.5% | CL |
| ROA | 2.9% | 3.9% | CL |
| Total Assets | 42.09B | 16.61B | EMR |
| Debt/Equity | 0.37 | 54.74 | EMR |
| Current Ratio | 0.87 | 1.02 | CL |
Frequently Asked Questions
Based on our detailed analysis, CL is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.